approval. in europe and the uk. and that approval, if it does come, might happen approval, if it does come, might happen next year. but then, a lot more happen next year. but then, a lot more needs happen next year. but then, a lot more needs to happen after that. so, first of more needs to happen after that. so, first of all. more needs to happen after that. so, first of all, let me stress, this is ust first of all, let me stress, this is just for first of all, let me stress, this is just for early stage, people in the early just for early stage, people in the early stages of alzheimer s. but then early stages of alzheimer s. but then there are all kinds of other barriers then there are all kinds of other barriers to then there are all kinds of other barriers to getting this drug. it may barriers to getting this drug. it may cost barriers to getting this drug. it may cost tens of thousands of pounds per year may cost tens of thousands of pounds per year per may c
New Delhi [India], November 17 (ANI/SRV): Surat Hematology Centre, a comprehensive diagnostic and treatment facility for Hematological malignancies and other blood disorders for both adults and children, has become the first centre of excellence in Hematology and Bone Marrow Transplant (BMT) in South Gujarat. Surat Hematology Centre is the 1st comprehensive hematology and Bone Marrow Transplant centre in Surat with a broad array of services like diagnosis and management of benign and malignant hematology, immunodeficiency disorders like SCID, CVID, CGD, HLH and for autologous, allogeneic and haploidentical bone marrow and stem cell transplants. The centre has advanced laboratory facilities with hemolytic tests and detection as well as treatment of blood disorders. Among the multitude of procedures offered by the Surat Hematology Centre, the most popular ones are bone marrow aspiration and biopsy sternal, PSIS, lumbar puncture, intrathecal chemotherapy, germline mutational cases of leuk
The central vein sign is an emerging neuroimaging biomarker for multiple sclerosis that may reduce the need for lumbar puncture to detect oligoclonal bands in CSF, a pilot study shows.